Skip to main content
. Author manuscript; available in PMC: 2019 Jun 14.
Published in final edited form as: J Med Chem. 2018 May 24;61(11):4946–4960. doi: 10.1021/acs.jmedchem.8b00419

Table 2.

Statistics for docking abiraterone and its analogs into CYP17A1 and CYP21A2

Inhibitor ΔGbind (kcal/mol)
CYP17A1 CYP21A2
Abiraterone (1b) −42.6 −11.9
8 −43.8 11.4
7 −42.6 −1.1
6b −46.6 −6.4
12b −48.0 2.4
10b −46.6 −4.3
13b −49.0 8.5